| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Oil-What a Difference A Month Can Make |
|
Answers - Oil-What a Difference A Month Can Make
Just one month ago President Bush marked Labor Day by promising to keep U.S. workers competitive in global markets and to reduce U.S. reliance on foreign oil. "Dependence on foreign oil jeopard According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ized our capacity to grow," he noted. Encouraging words yes, but hardly new. President Richard M. Nixon promised in 1971 to make the United States self-sufficient in energy by 1980. President ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Jimmy Carter promised in 1979 that the nation would "never again use more foreign oil than we did in 1977." When times are tough, we look for alternatives. When times are rosy, we stick our he lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. d back into the oil sands. Wall Street advanced Wednesday taking the Dow Jones industrial further into record high territory, as oil prices fell for a third straight day. The government surpri here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe sed penny stock investors by reporting a rise in crude oil inventories. Saudi Arabia also said the country wanted to keep oil prices low. "It looks like the petroleum data shows that there is d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ore than enough oil to go around," mused one research analyst. Oil prices settled at a seven-month low below $59 a barrel this week as rising global supplies, slack demand, and a mild Atlantic ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc hurricane season forced geopolitical worries to the back burner. "For the next three months, there is nothing in the fundamentals that is likely to support higher prices except an OPEC produc easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tion cutback," predicted one energy analyst. Not surprisingly, OPEC's president said Thursday that the group is considering an emergency meeting to discuss the possibility of cutting output. B nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t fear not, Michael Lynch, President of Strategic Energy & Economic Research predicts that oil will fall to $45 per barrel by mid-2007 and could dip briefly into the $20s in 2008. Sometime next and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ year, he expects we are going to see $1.95 price at the pumps. While the idea of cheap oil is a godsend for most Americans, it does absolutely nothing to decrease our dependency on foreign oi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi . And by foreign oil, I'm referring to politically unstable areas such as the Middle East and Venezuela. For arguments sake, let's not refer to Canada's ubiquitous oil sands as "foreign". Stil ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a l, cheap oil puts the idea of alternative energy sources on the backburner...and out of the limelight for most investors. But insightful penny stock investors could see the lack of media intere dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod st on alternative energy sources as a chance to invest in companies whose day in the sun...could be just around the corner. While I love to listen to energy savvy prognosticators, if there's o cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e thing we can accurately predict, it's that things rarely go as smoothly as we like. Especially when we are not in the driver's seat. We can't rely on geopolitical tensions and a decrease in tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen demand to stay with us indefinitely. Should simmering tensions overseas suddenly boil over, you can expect energy prices to follow suit. Sure they'll retrace at some point, but with penny stoc t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s and the stock market in general, prices can rise and fall quite drastically in a very short period of time. Remember, the stock market is all about marketing; penny stocks rise and fall on p ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ress releases, speeches, bad weather reports and the 6 o'clock news. So, when is the best time to take advantage of some penny stocks? When they're being overlooked. One month ago, we were dis y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products cussing alternative energy sources. No-one seems to be now. Oil has its substitutes: biofuels, solar power, electrical automobiles, and renewable-source electricity generation. Other untested . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de echnologies also exist and are waiting to be developed further. But they cannot compete with oil as long as it's cheap. Which is good news for astute penny stock investors looking to capitaliz elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e on a hot sector that is, right now, lukewarm. Alternative energy sources may not be the talk of Wall Street right now, but it only takes one news story for that murmuring to get a lot louder tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Waterless Hibernation of Fishes is Good for Business Make Money on eBay - Don't Give Up Too Soon!
|